| MR编号 | AT/H/1274/001 |
|---|
| 药品名称 | Beclometasone/ Formoterol Cipla 100/6 micrograms/actuation, pressurised inhalation, solution |
|---|
| 活性成分 | - Beclometasone dipropionate 100.0 µg/dose
- Formoterolfumarat dihydrate 6.0 µg/dose
|
|---|
| 剂型 | Pressurised inhalation, solution |
|---|
| 上市许可持有人 | Cipla Europe NV
De Keyserlei 58-60, Bus 19
2018 Antwerp |
|---|
| 参考成员国 - 产品名称 | Austria (AT) |
|---|
| 互认成员国 - 产品名称 | - Italy (IT)
- Sweden (SE)
- Norway (NO)
- Bulgaria (BG)
Beclometasone/ Formoterol Cipla - Czechia (CZ)
BIBECFO 100 mikrogramů/6 mikrogramů/dávka roztok k inhalaci v tlakovém obalu - Romania (RO)
- Slovakia (SK)
- Germany (DE)
Beclometason/ Formoterol Cipla 100/6 Mikrogramm/Sprühstoß, Druckgasinhalation, Lösung - France (FR)
- Spain (ES)
|
|---|
| 许可日期 | 2023/11/09 |
|---|
| 最近更新日期 | 2024/11/06 |
|---|
| 药物ATC编码 | - R03AK08 formoterol and beclometasone
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|